Alvotech (ALVO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.00, -5.84% vs the prior close of $5.31.
- Volume 1.06M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ALVO slides 5.8% to $5.00, a 1-month low. Closed at $5.00, -5.84% vs the prior close of $5.31. Day range $4.95β$5.27, opened at $5.27.
ALVO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ALVO slides 5.8% to $5.00, a 1-month low
- Closed at $5.00, -5.84% vs the prior close of $5.31. Day range $4.95β$5.27, opened at $5.27.
- Volume was 1.06M shares, 0.9x its 50-day average of 1.12M.
- Price is -2.7% vs its 50-day average ($5.14) and +18.8% vs its 200-day average ($4.21).
- 52-week range $2.94β$9.00; today's close sits at 34% of that range, 44.4% below the 52-week high.
Oct 15, 2026 β ALVO rises 2.7% to $5.31
- Closed at $5.31, +2.71% vs the prior close of $5.17. Day range $5.13β$5.39, opened at $5.15.
- Volume was 1.16M shares, 1.0x its 50-day average of 1.11M.
- Price is +3.8% vs its 50-day average ($5.11) and +26.2% vs its 200-day average ($4.21).
- 52-week range $2.94β$9.05; today's close sits at 39% of that range, 41.3% below the 52-week high.
Oct 14, 2026 β ALVO slides 3.9% to $5.17, 3 down days in a row
- Closed at $5.17, -3.90% vs the prior close of $5.38. Day range $5.15β$5.51, opened at $5.32.
- Volume was 1.05M shares, 1.0x its 50-day average of 1.10M.
- Price is +1.7% vs its 50-day average ($5.08) and +22.9% vs its 200-day average ($4.21).
- 52-week range $2.94β$9.05; today's close sits at 37% of that range, 42.8% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
Oct 13, 2026 β ALVO dips 2.2% to $5.38
- Closed at $5.38, -2.18% vs the prior close of $5.50. Day range $5.31β$5.64, opened at $5.51.
- Volume was 1.21M shares, 1.1x its 50-day average of 1.10M.
- Price is +6.4% vs its 50-day average ($5.06) and +27.9% vs its 200-day average ($4.21).
- 52-week range $2.94β$9.05; today's close sits at 40% of that range, 40.5% below the 52-week high.
Oct 12, 2026 β ALVO slides 4.8% to $5.50
- Closed at $5.50, -4.84% vs the prior close of $5.78. Day range $5.44β$5.89, opened at $5.79.
- Volume was 841.00K shares, 0.8x its 50-day average of 1.12M.
- Price is +9.5% vs its 50-day average ($5.02) and +30.7% vs its 200-day average ($4.21).
- 52-week range $2.94β$9.05; today's close sits at 42% of that range, 39.2% below the 52-week high.
Oct 9, 2026 β ALVO rises 1.9% to $5.78
- Closed at $5.78, +1.94% vs the prior close of $5.67. Day range $5.57β$5.80, opened at $5.67.
- Volume was 707.10K shares, 0.6x its 50-day average of 1.12M.
- Price is +15.7% vs its 50-day average ($5.00) and +37.5% vs its 200-day average ($4.20).
- 52-week range $2.94β$9.05; today's close sits at 47% of that range, 36.1% below the 52-week high.
Oct 8, 2026 β ALVO slides 3.1% to $5.67
- Closed at $5.67, -3.08% vs the prior close of $5.85. Day range $5.61β$5.83, opened at $5.83.
- Volume was 668.90K shares, 0.6x its 50-day average of 1.17M β lighter than usual.
- Price is +14.5% vs its 50-day average ($4.95) and +35.0% vs its 200-day average ($4.20).
- 52-week range $2.94β$9.05; today's close sits at 45% of that range, 37.3% below the 52-week high.
Oct 7, 2026 β ALVO slides 4.7% to $5.85
- Closed at $5.85, -4.72% vs the prior close of $6.14. Day range $5.84β$6.14, opened at $6.10.
- Volume was 864.60K shares, 0.7x its 50-day average of 1.16M.
- Price is +19.2% vs its 50-day average ($4.91) and +39.4% vs its 200-day average ($4.20).
- 52-week range $2.94β$9.05; today's close sits at 48% of that range, 35.3% below the 52-week high.
- SEC filings that day: 6-K.
Oct 6, 2026 β ALVO rises 0.5% to $6.14
- Closed at $6.14, +0.49% vs the prior close of $6.11. Day range $6.00β$6.17, opened at $6.07.
- Volume was 1.22M shares, 1.1x its 50-day average of 1.14M.
- Price is +26.5% vs its 50-day average ($4.85) and +46.5% vs its 200-day average ($4.19).
- 52-week range $2.94β$9.05; today's close sits at 52% of that range, 32.1% below the 52-week high.
Oct 5, 2026 β ALVO jumps 12.1% to $6.11 on 2.6x normal volume
- Closed at $6.11, +12.11% vs the prior close of $5.45. Day range $5.90β$6.53, opened at $5.99.
- Volume was 2.90M shares, 2.6x its 50-day average of 1.10M β unusually heavy trading.
- Price is +27.5% vs its 50-day average ($4.79) and +46.0% vs its 200-day average ($4.18).
- 52-week range $2.94β$9.05; today's close sits at 52% of that range, 32.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 2, 2026 β ALVO slides 3.0% to $5.45, 4 down days in a row
- Closed at $5.45, -3.02% vs the prior close of $5.62. Day range $5.43β$5.70, opened at $5.61.
- Volume was 750.90K shares, 0.7x its 50-day average of 1.11M.
- Price is +15.2% vs its 50-day average ($4.73) and +30.4% vs its 200-day average ($4.18).
- 52-week range $2.94β$9.05; today's close sits at 41% of that range, 39.7% below the 52-week high.
- That makes 4 straight losses.
ALVO latest news & SEC filings
Every SEC filing by or about ALVO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 7, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 31, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 21, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 19, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 29, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 1, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 30, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ALVO
- How much it moves: over the last 20 sessions the average daily move was 3.27% (largest 12.1%). That is a volatile stock.
- Liquidity: about 1.12M shares (β$5.58M) trade per day on average.
- 52-week position: $5.00 vs a range of $2.94β$9.00 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 14, 2026; 6-K Oct 7, 2026; 6-K Oct 5, 2026.
- Listing: Nasdaq Β· industry: Biological Products, (No Diagnostic Substances).
ALVO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.27 | 5.27 | 4.95 | 5.00 | 1.06M |
| Oct 15, 2026 | 5.15 | 5.39 | 5.13 | 5.31 | 1.16M |
| Oct 14, 2026 | 5.32 | 5.51 | 5.15 | 5.17 | 1.05M |
| Oct 13, 2026 | 5.51 | 5.64 | 5.31 | 5.38 | 1.21M |
| Oct 12, 2026 | 5.79 | 5.89 | 5.44 | 5.50 | 841.00K |
| Oct 9, 2026 | 5.67 | 5.80 | 5.57 | 5.78 | 707.10K |
| Oct 8, 2026 | 5.83 | 5.83 | 5.61 | 5.67 | 668.90K |
| Oct 7, 2026 | 6.10 | 6.14 | 5.84 | 5.85 | 864.60K |
| Oct 6, 2026 | 6.07 | 6.17 | 6.00 | 6.14 | 1.22M |
| Oct 5, 2026 | 5.99 | 6.53 | 5.90 | 6.11 | 2.90M |
| Oct 2, 2026 | 5.61 | 5.70 | 5.43 | 5.45 | 750.90K |
| Oct 1, 2026 | 5.81 | 5.82 | 5.46 | 5.62 | 1.20M |
| Sep 30, 2026 | 5.95 | 5.97 | 5.76 | 5.80 | 1.14M |
| Sep 29, 2026 | 6.14 | 6.17 | 5.82 | 5.92 | 1.17M |
| Sep 28, 2026 | 5.73 | 6.17 | 5.68 | 6.15 | 1.44M |
| Sep 25, 2026 | 5.90 | 5.90 | 5.67 | 5.75 | 705.20K |
| Sep 24, 2026 | 5.75 | 6.06 | 5.75 | 5.88 | 1.20M |
| Sep 23, 2026 | 5.86 | 5.89 | 5.70 | 5.81 | 774.00K |
| Sep 22, 2026 | 5.90 | 5.97 | 5.72 | 5.84 | 975.90K |
| Sep 21, 2026 | 5.92 | 5.98 | 5.74 | 5.88 | 1.31M |
About Alvotech
Alvotech (ALVO) is listed on the Nasdaq and classified by the SEC under βBiological Products, (No Diagnostic Substances)β. Its business address is in LUXEMBOURG, Luxembourg. State of incorporation: Luxembourg. Fiscal year ends December 31. SEC CIK 1898416.
ALVO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ALVO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
ALVO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ALVO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.